Skip to main content
Signal8

Quinlan Amy

SEC insider (Form 3/4/5 filer). CIK 0002027706. Principal Accounting Officer at Voyager Therapeutics, Inc. (VYGR) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Nov 6, 2024. Located in CAMBRIDGE, MA.

Companies Quinlan Amy has filed insider reports for

  • Voyager Therapeutics, Inc. (VYGR): Officer, Principal Accounting Officer
  • Vor Biopharma Inc. (VOR): Officer, Vice President of Finance
Quinlan Amy profile photo

Quinlan Amy

CIK: 0002027706

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)5 (100.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Voyager Therapeutics, Inc. logo
VYGR

Voyager Therapeutics, Inc.

Officer
Vor Biopharma Inc. logo
VOR

Vor Biopharma Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Vor Biopharma Inc. logo
    VOR

    Vor Biopharma Inc.

    Nov 6, 2024
    Tax Payment
    Direct
    206 shares at avg. $0.86$177.16
  • Vor Biopharma Inc. logo
    VOR

    Vor Biopharma Inc.

    Nov 1, 2024
    Tax Payment
    Direct
    343 shares at avg. $0.80$274.4
  • Vor Biopharma Inc. logo
    VOR

    Vor Biopharma Inc.

    Sep 3, 2024
    Tax Payment
    Direct
    4.4K shares at avg. $0.83$4K
  • Vor Biopharma Inc. logo
    VOR

    Vor Biopharma Inc.

    Aug 6, 2024
    Tax Payment
    Direct
    206 shares at avg. $0.87$179.22
  • Vor Biopharma Inc. logo
    VOR

    Vor Biopharma Inc.

    Aug 1, 2024
    Tax Payment
    Direct
    343 shares at avg. $0.94$322.42

1-5 of 5